Market leader and industry pioneer in genetic diagnostics acquired by global medical technology company

13. Dezember 2017

DEAL FLASH:

Oaklins’ team in Los Angeles has advised the shareholders of Ambry Genetics Corporation, a clinical diagnostics testing services provider, on the sale of the company to Konica Minolta, Inc.

This powerful combination will bring the most comprehensive genetic diagnostic solutions to Japan, Europe and globally.

Read more about the transaction, market trends, deal drivers and M&A valuation aspects.